| Investor | Value | Of portfolio | Shares | Change | Quarter |
|---|---|---|---|---|---|
| Maverick Capital · Lee Ainslie | $3.2M | 0.03% | 3.97M | — | Q2 2026 |
| Renaissance Technologies | $97.1K | 0.00% | 122.20K | +247% | Q2 2026 |
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a GUTS trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 13, 2026 | Bradley William CDirector | Purchase at price 0.62 per share. | 64.5K | $39.90K |
| Jun 11, 2026 | Royan Ajay G.Director | Purchase at price 0.85 per share. | 23K | $19.60K |
| Jun 9, 2026 | Bradley William CDirector | Purchase at price 0.73 per share. | 68.5K | $50.33K |
| Jun 9, 2026 | Sheffield IanDirector | Purchase at price 0.73 per share. | 35K | $25.53K |
| Jun 9, 2026 | Rajagopalan Harith M.D., Ph.D.Chief Executive Officer | Purchase at price 0.73 per share. | 25K | $18.25K |
| Jun 7, 2026 | Smith Weber LaraChief Financial Officer | Purchase at price 0.69 per share. | 20K | $13.71K |
| Dec 3, 2025 | Rajagopalan Harith M.D., Ph.D.Chief Executive Officer | Purchase at price 1.92 per share. | 10.4K | $20.00K |
| Mar 13, 2025 | Royan Ajay G.Director and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.28 per share. | 17.9K | $22.98K |
| Mar 13, 2025 | Barnes Kelly AnnDirector | Purchase at price 1.30 per share. | 31K | $40.21K |
| Mar 12, 2025 | Bradley William CDirector | Purchase at price 1.26 per share. | 16.1K | $20.36K |
| Mar 12, 2025 | Schulman Amy W.Director | Purchase at price 1.17 per share. | 8.6K | $9.96K |
| Mar 12, 2025 | Conaway SamuelDirector | Purchase at price 1.17 per share. | 8.6K | $9.96K |
| Jan 30, 2025 | Caplan Jay DavidPresident | Sale at price 1.81 - 1.95 per share. | 43.8K | $82.27K |
| Jan 30, 2025 | Rajagopalan Harith M.D., Ph.D.Chief Executive Officer | Sale at price 1.82 - 1.95 per share. | 111.9K | $206.00K |
| Jan 30, 2025 | Caplan Jay DavidPresident | Conversion of Exercise of derivative security at price 1.70 per share. | 43.8K | $74.49K |
| Jan 30, 2025 | Rajagopalan Harith M.D., Ph.D.Chief Executive Officer | Conversion of Exercise of derivative security at price 1.70 per share. | 111.9K | $190.26K |
| Nov 10, 2024 | Caplan Jay DavidPresident | Sale at price 2.47 per share. | 64.2K | $158.54K |
| Nov 10, 2024 | Rajagopalan Harith M.D., Ph.D.Chief Executive Officer | Sale at price 2.47 per share. | 96.5K | $238.36K |
| Nov 7, 2024 | Caplan Jay DavidPresident | — | 187.3K | — |
| Nov 7, 2024 | Rajagopalan Harith M.D., Ph.D.Chief Executive Officer | — | 216.9K | — |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -79.1 | 2.0 | -2.3 | 39.3 | 26.3 | -1.5 | -13.7 | 3.8 | -23.5 | -36.8 | −84.4% | ||
| 2025 | -10.7 | -15.2 | -23.7 | 6.7 | 49.6 | -14.7 | 13.6 | -47.2 | 63.7 | -22.6 | 27.6 | 40.1 | +6.8% |
| 2024 | -17.8 | -8.6 | -0.3 | -36.6 | -25.3 | 9.7 | -27.7 | 11.3 | -9.1 | -19.5 | −77.1% |
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. It develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. The company also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.
Buy / hold / sell counts